drug
as of 2026-07-01clemastine (8 mg/day)
at a glance
small molecule
Pre-approval / investigational in the US
Developed by LMU Klinikum
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
NCT06315972Phase 2Not Yet Recruiting
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication